Cognitive changes after 50 are one of the areas where traditional primary care most consistently falls short. Not because individual physicians don't care, but because a 15-minute visit doesn't allow the kind of observation and follow-up required to catch subtle changes early. Many of the conditions that present as cognitive symptoms are treatable when identified. Others benefit significantly from early intervention. Here's what I actually screen for and how the concierge model handles this differently.
TL;DR
- Cognitive symptoms after 50 often have treatable causes that get missed in 15-min visits: B12 deficiency, thyroid dysfunction, sleep apnea, medication effects, chronic inflammation, depression, vascular risk factors, substance use
- The structural problem isn't physician negligence; it's the absence of continuity required to notice subtle pattern changes over time
- Real workup includes comprehensive labs (CBC, CMP, TSH/free T4/free T3, B12, methylmalonic acid, vitamin D, hs-CRP, homocysteine, advanced lipids, A1C), validated cognitive testing when indicated, imaging when the clinical picture warrants
- For reversible causes, early identification often produces substantial improvement within weeks to months
- For progressive conditions, early detection enables vascular optimization, exercise programs, sleep optimization, and emerging treatments that work best when started early
- To reach the practice: call 561-468-6981
Why this gets missed in traditional care
When you see a different physician each visit, when appointments are squeezed between 15 other patients, and when the electronic record demands more attention than the patient does, subtle changes in memory, processing speed, and executive function don't get noticed. The patient mentions being more forgetful. The spouse notices something seems different. Those observations get documented briefly, then lost among acute concerns (blood pressure, cholesterol, that knee pain).
Patients who've transferred to my practice often report years of these observations with no one connecting them. The meaningful question is not "was anyone rude or negligent." It's "was anyone in a position to notice the pattern." Usually no one was.
The treatable causes I look for
Many causes of cognitive symptoms are entirely reversible or responsive to treatment. These are the frequently-overlooked culprits worth screening for:
- Vitamin B12 deficiency. Common in adults over 50, especially those taking metformin or acid-reducing medications. Can produce symptoms that mimic early dementia and resolves with appropriate supplementation.
- Thyroid dysfunction. Even subtle abnormalities in TSH, free T4, or free T3 can significantly affect cognition, mood, and energy.
- Sleep apnea. Extremely common and often undiagnosed. Untreated apnea directly accelerates cognitive aging. (The executive-specific deep dive on missed sleep apnea.)
- Medication side effects and interactions. Benzodiazepines, anticholinergics, certain sleep aids, some antidepressants, and common combinations can impair cognition. Polypharmacy is a major contributor in older patients.
- Chronic inflammation. Elevated inflammatory markers (hs-CRP, homocysteine) correlate with cognitive decline. Addressing underlying drivers often improves things. (How chronic stress drives this same inflammatory pattern.)
- Depression and anxiety. Can present as cognitive impairment ("pseudodementia") and are highly treatable. (How depression and anxiety care work in concierge primary care.)
- Vascular risk factors. Poorly controlled blood pressure, diabetes, and lipid profiles directly damage small vessels in the brain. Aggressive management of vascular risk protects cognition.
- Substance use. Alcohol specifically, but also THC, sleep aids, and some supplements. Often underreported.
Each of these requires attention and follow-through to identify. In a rushed appointment, it's easy to attribute cognitive complaints to "aging" and move on.
What comprehensive brain health monitoring looks like
When a new patient joins my practice, I establish a cognitive baseline. This isn't a quick screening test administered by a medical assistant. It's a real conversation about how they think, remember, process information, and navigate daily life. I learn what's normal for them specifically.
From there, monitoring for change happens over time. Because I see patients regularly and know them well, I notice shifts. Word-finding problems that are new. A spouse mentioning that questions are being asked repeatedly. Difficulty managing medications or finances that wasn't there before. In a longitudinal relationship, these observations accumulate into a picture. In episodic care, they get documented in isolation.
Laboratory workup when indicated includes comprehensive panels rather than just the insurance-covered minimum. CBC, CMP, TSH with free T4 and free T3, B12 and methylmalonic acid, vitamin D, inflammatory markers (hs-CRP, homocysteine), lipid panel with particle analysis, A1C, and hormone panels when clinical picture warrants. Cognitive testing through validated instruments when appropriate. Imaging when indicated by the clinical pattern. (How sleep itself drives cognitive and metabolic outcomes.)
For families and adult children
Adult children whose parents split time in Palm Beach County or live here year-round often worry about cognitive oversight. Having a physician who sees the parent regularly, establishes baseline, and catches changes early is one of the most useful interventions available for this situation.
When something seems off, the adult child wants a physician who can actually say "yes, that's different from what I've been seeing" or "no, that's consistent with baseline." Without that longitudinal relationship, that kind of call can't be made. (How emergency situations with aging parents work better with this kind of relationship.)
What early intervention actually changes
For reversible causes (B12, thyroid, sleep apnea, medication effects, depression), early identification often produces substantial cognitive improvement within weeks to months.
For progressive conditions like early Alzheimer's or vascular cognitive impairment, early detection enables interventions that can slow progression: vascular risk optimization, exercise programs (aerobic exercise has strong data for cognitive protection), sleep optimization, medication review to remove cognition-impairing drugs, and for Alzheimer's specifically, emerging treatments that work best when started early.
For all of these, the benefit of catching issues early is substantial.
Frequently Asked Questions
Is some cognitive decline just normal aging?
Yes, but less than people assume. Normal aging includes mild slowing of processing speed and occasional word-finding difficulty. It doesn't include functional impairment (difficulty managing finances or medications), repeated questions, getting lost in familiar places, or significant personality change. When patients or families ask "is this normal?" the honest answer is usually "let's establish what's actually happening and decide based on that," not a reflexive "yes, it's just aging."
What's the difference between mild cognitive impairment (MCI) and dementia?
MCI is measurable cognitive change that doesn't yet impair daily function. Dementia is cognitive change severe enough to impair function (managing money, medications, household, work). MCI doesn't always progress to dementia; some patients stay stable for years, some improve when reversible causes are addressed, some progress. Identifying MCI early matters because it's the window where intervention has the most leverage.
Are over-the-counter brain supplements (Prevagen, Neuriva, etc.) effective?
The evidence for most consumer brain supplements is weak. Prevagen specifically has been the subject of FTC enforcement actions over its claims. The interventions with real evidence behind them are unglamorous: aerobic exercise, sleep optimization, blood pressure control, blood sugar control, treatment of depression and sleep apnea, social engagement, and addressing reversible causes (B12, thyroid). Supplements aren't where the leverage is.
What about lecanemab (Leqembi) and donanemab (Kisunla) for early Alzheimer's?
These are recently-approved monoclonal antibody treatments for early Alzheimer's that work by reducing amyloid plaques. They show modest slowing of cognitive decline in carefully selected patients. They're not cures, they're not appropriate for all patients, they require specific imaging confirmation of amyloid pathology, and they have meaningful side effects (ARIA, brain swelling) requiring monitoring. The decision to start one is specialist-driven, but the early-detection-through-primary-care piece is what makes appropriate referral possible.
Does coronary artery calcium scoring tell you anything about brain health?
Indirectly, yes. CAC reflects atherosclerotic burden in the coronary arteries, which correlates with vascular risk in the brain (the small-vessel disease that drives vascular cognitive impairment). High CAC scores warrant aggressive vascular risk management for brain protection as well as heart protection. The approach is the same: blood pressure, lipids, blood sugar, smoking, exercise. (Full breakdown of advanced cardiovascular screening.)
What if my parent refuses cognitive screening?
This is common and difficult. The framing that often works: this isn't about catching dementia, it's about identifying treatable causes (sleep, medications, thyroid, B12) that may be making things harder than they need to be. Most patients are willing to engage on those terms. If a parent won't engage at all, working through their primary care physician with the spouse or adult child as the third party can help; resistance often reflects fear, not rejection of the idea.
How to evaluate any practice for serious cognitive monitoring
The criterion is whether the physician will establish a real baseline, see you regularly enough to notice changes, and run a comprehensive workup when indicated rather than defaulting to "it's just aging." Panel size below 300 is a reasonable proxy for the time required to do this work well. (Full criteria for evaluating any concierge practice.)
About the Author
Dr. Ben Soffer, DO is a board-certified physician practicing concierge primary care in Boca Raton, Florida. He caps his practice at 50 patients, which is what makes the kind of longitudinal cognitive monitoring described above the actual operating model rather than a checklist on an EMR.
If you've noticed changes in yourself or a family member
A no-obligation conversation about your specific situation, including the honest answer about whether what you're noticing warrants a real evaluation.
- Call: 561-468-6981
- Email: info@drbensoffer.com
- Or reach out through the contact form
